Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. (Record no. 25180201)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02170 a2200649 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517045939.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201612s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1029-2403 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.3109/10428194.2015.1075019 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Holkova, Beata |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20161213 |
| 245 00 - TITLE STATEMENT | |
| Title | Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Leukemia & lymphoma |
| Date of publication, distribution, etc. | 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 635-43 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Biomarkers |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Combined Modality Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cytokines |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Monitoring |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Resistance, Neoplasm |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hydroxamic Acids |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphoma, B-Cell |
| General subdivision | blood |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Recurrence, Local |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oligopeptides |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retreatment |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Vorinostat |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kmieciak, Maciej |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bose, Prithviraj |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yazbeck, Victor Y |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barr, Paul M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tombes, Mary Beth |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shrader, Ellen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Weir-Wiggins, Caryn |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rollins, April D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cebula, Erin M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pierce, Emily |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Herr, Megan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sankala, Heidi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hogan, Kevin T |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wan, Wen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Feng, Changyong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peterson, Derick R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fisher, Richard I |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grant, Steven |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Friedberg, Jonathan W |
| 773 0# - HOST ITEM ENTRY | |
| Title | Leukemia & lymphoma |
| Related parts | vol. 57 |
| -- | no. 3 |
| -- | p. 635-43 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.3109/10428194.2015.1075019">https://doi.org/10.3109/10428194.2015.1075019</a> |
| Public note | Available from publisher's website |
No items available.